Researchers assessed the extent to which new or growing nodules detected on follow-up rounds of LDCT lung cancer screening indicated the risk for malignancy.
CyPath Lung, bioAffinity Technologies' noninvasive test for lung cancer, will be featured at the Cleveland Clinic's annual ...
AstraZeneca and Telangana government have partnered to implement AI-driven lung cancer screening across 20 public health ...
As lung cancer screening identifies an estimated 1.6 million suspicious lung nodules each year in the U.S. alone, physicians ...
Why the World's Leading Medical Robotics Companies Put Clinical Value FirstThis article serves as a foundational study for the Noah Medical deep-dive ...
Vietnam Investment Review on MSN
Noah Medical launches medical robotics research series
HONG KONG, April 13, 2026 /PRNewswire/ -- Noah Medical has released the first article in its deep-dive research series on medical robotics, highlighting a major industry shift toward early-stage ...
Screening rules are too narrow and keep patients from receiving care until it’s too late, say many Boston-area researchers ...
On April 9, 2026, Oxford BioTherapeutics announced a multi-year collaboration with Bristol Myers Squibb focused on the discovery and development of T-cell engager therapies for solid tumors. 1 ...
Lung cancer is the second most common type of cancer and the leading cause of cancer deaths worldwide. Early-stage lung cancer is often asymptomatic, meaning patients are typically diagnosed at an ...
It's the deadliest cancer in the US, killing about 125,000 annually. As more fit, healthy people receive the devastating ...
Northwell Health Physician Partners (NHPP) has opened Primary and Specialty Care at Chappaqua Crossing, Photographs courtesy Northwell Health. On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results